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1. Introduction 
Scientific advances in understanding the cellular-molecular-genetic mechanisms of 
carcinogenesis (Coleman et al., 2006; Finn, 2008) and the impressive advances in the 
treatment of cancer in animal models clearly not correspond to the results of clinical studies 
(Knight et al., 2006). Cancer process is still uncontrollable and global forecasts are 
disappointing: in the world by 2050 will increase from 11 up to 24 million new cases and 
death rate – from 6 (in 1999) up to 16 million (Boyle et al., 2005). In addition, despite 
enormous progress in understanding biology of malignant tumors and mechanisms of 
carcinogenesis, the constant improvement of malignant tumor treatment methods the five 
years’ survival rate of cancer patients has increased only by 14% - from 50% up to 64% over 
the past 30 years (Herbst et al., 2006). Obviously, there is a large gap between the cancer 
science and clinical oncology practice and it is constantly increasing as the molecular-genetic 
research technologies develop which lead scientists from a holistic vision of the person. 
Now considering the problem of cancer from the standpoint of experimental animal models 
and the three officially accepted types of carcinogenesis (chemical, physical & biological) is 
not enough. 
We believe that there is the fourth type of carcinogenesis – psychogenic carcinogenesis 
(Bukhtoyarov & Samarin, 2009) the idea of the existence was generated during the clinical 
work with cancer patients. Thus, the multicenter anamnestic study of causes of cancer 
among 1200 cancer patients with 23 kinds of cancer from three regions of Russia and 
Kazakhstan showed that 50%-70% of cancer patients were determined by psychogenic 
factors (death of the close person, divorce, frequent family conflicts, change of residence, 
appearance of the disabled in family etc.), as the major ones in the appearance of malignant 
tumors (Bukhtoyarov & Arkhangelskiy, 2008). Understanding of psychogenic 
carcinogenesis would allow to find the new ways to solve many problems in modern 
oncology and to form the holistic approach to the cancer problem. 
2. Psychogenic carcinogenesis: A new look at old problems 
At present, a huge number of various scientific and clinical evidence was accumulated that 
can not be explained in terms of the existing views on the mechanisms of carcinogenesis. 
However, these facts can be explained by the pathogenetically meaningful participation of 
the psyche in the appearance, progression and recurrence of cancer. Ignoring this 
understanding explains much of uncontrollability and unpredictability of the flow of the 
cancer process in some cancer patients, and also explains the considerable difficulties in 
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creating effective anti-cancer drugs. The main factor triggering the activation mechanisms of 
psychogenic carcinogenesis is a chronic debilitating psycho-emotional stress (CPS). 
2.1 Chronic psycho-emotional stress and carcinogenesis 
It is known that two interconnected processes are necessary for developing of a cancer 
under influence of chemical, physical or biological carcinogenic factors: genetic break/cell 
DNA damage and compromising of the immune system. However, these pathological 
processes can be generated without participation of exogenous carcinogens, i.e. can be 
induced psychogenically. Chronic psycho-emotional stress is capable to activate key 
carcinogenic mechanisms and to induce malignant tumor growth.  
2.1.1 Chronic psycho-emotional stress and DNA damage 
It is known that CPS leads to dysfunction of telomere (the ends of chromosomes) and to 
reduction of their length (Epel et al., 2004; Arehart-Treichel, 2005), which is accompanied by 
genome instability, acceleration of biological ageing (Simon et al., 2006), reduction of life 
expectancy (Kimura et al., 2008), formation of a lot of diseases including cardiovascular 
diseases and cancer (Anisimov, 2007). Short telomeres are biomarkers of cell ageing; they 
specify stressful history of a cell and cumulative action of a high level of oxidant stress on a 
cell (von Zglinicki & Martin-Ruiz, 2005). In its turn oxidant stress is capable to be activated 
in reply to CPS and damage DNA, lead to gene mutations by means of reactive oxygen and 
nitrogen species (RONS) that becomes critical event in activation of key tumorogenesis 
mechanisms (Gidron et al., 2006; Halliwell, 2007; Toyokuni, 2008). Person in condition of 
CPS is very sensitive to damaging action of various mutagens, spontaneous and induced 
levels of damage of DNA are more often registered (Dimitroglou et al., 2003). The chronic 
stress in model in vivo facilitates development of skin cancer almost in 3 times on a 
background of carcinogenic action of ultra-violet irradiation (Saul et al., 2006). 
2.1.2 Chronic psycho-emotional stress and compromised immunity 
Genetic damages are necessary but insufficient for the neoplastic transformation of the cells 
and tumor growth, cancer progressing or relapse as formation of tumor is impossible 
without infringements in immune system where stressful factors and mentality take an 
active part (Schussler & Schubert, 2001), that is a subject of studies psychoneuro-
immunology and its sub-discipline – psychoimmunology of cancer (Lewis et al., 2002). On 
background of CPS decreased hypothalamo–pituitary–adrenal (HPA) and sympathetic–
adrenal–medullary (SAM) axes responsiveness is observed that is accompanied with 
disregulation of neuromediator systems, infringement of hormonal expression and 
functions of immune system (Reiche et al., 2005; Ostrander et al., 2006). 
At the cellular level stressed and depressed patients had overall leukocytosis, high 
concentration of circulating neutrophils, reduced mitogen-stimulated lymphocyte proliferation 
and neutrophil phagocytosis. At the molecular level high levels of serum basal cortisol, acute 
phase proteins, chemokines, adhesion molecules, plasma concentration of interleukins IL-1, IL-
6, and TNF-alpha and a shift in the balance of Th1 and Th2 immune response towards 
humoral immunity. Both stress and depression were associated with the decreased cytotoxic 
T-lymphocytes and natural killer cell activities affecting the processes of the immune 
surveillance of tumors, the accumulation of somatic mutations and genomic instability. DNA 
damage, growth and angiogenic factors, proteases, matrix metalloproteinases and reactive 
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oxygen species were also related to the chronic stress response and depression (Reiche et al., 
2006). CPS induces apoptosis of lymphocytes and development of immune depression by 
means of glucocorticoid ways, participations of opiod systems (Wang et al., 2002), genes p53 
and P13R/nuclear factor kappaB (Zhang et al., 2008). 
In its turn oxidative stress also induced by CPS and depression supports immune 
suppression at malignant tumors (Corzo et al., 2007), and proinflamation cytokines, 
activated by mental depression, support a condition of mental depression (Dantzer et al., 
2008), closing some vicious circles of psychogenically induced carcinogenesis. 
2.1.3 Chronic psycho-emotional stress and chronic inflammation 
It is necessary to notice that CPS supports the centers of not stopping chronic inflammation 
which are always available in an organism due to activation in them of proinflammatory 
cytokines (Miller et al., 2002). Generation of RONS in the centers of slow inflammation 
considerably exceeds their opportunities of neutralization and elimination. Therefore high 
levels of oxidative-nitrosative stress and DNA damage are always registered in these centers 
that associates with the raised risk of tumor genesis and the main substances transforming 
the center of inflammation in the center of a tumor, are prostaglandins and cytokines 
(Federico et al., 2007; Kundu & Surh, 2008). Therefore, chronic inflammation may play a key 
role in carcinogenesis by causing DNA damage (Kawanishi et al., 2006). 
2.2 Chronic stress and cancer in vivo model 
In vivo model chronic stress is accompanied by a hypermetabolic syndrome with the severe 
loss of lean body mass, hyperglycemia, dyslipidemia, increased aminoacid turnover and 
acidosis. This was associated with hypercortisolism, hyperleptinemia, insulin resistance and 
hyperthyroidism that lead to a significant reduction of power reserves, compensatory 
opportunities and abilities of an organism to cope with infection or cancer (Depke et al., 
2008). Proof of chronic emotional stress connection with cancer development and progress 
was a result of experiments which have shown presence of IL-6-independent activation 
signal transducer and activator of transcription-3 through mediators of stress 
(norepinephrine and epinephrine), beta 1-/beta 2-adrenergic receptor and protein kinase A 
that has led to increased matrix metalloproteinase production, invasion and tumor growth 
(Landen et al., 2007). Besides chronic stress by means of beta-adrenergic activation induced 
the atrophy of thymus and the host resistance to tumors (Hasegawa & Saiki, 2005), and also 
induces resistance of tumoral cells to chemotherapy drugs through biological effects of 
adrenaline, alfa-2-adrenergic receptors and increase expression of a gene mdr1 which codes 
transport activity of plasma membrane ATPase, capable ‘‘to expel” molecules getting into a 
cell of cytostatic (Su et al., 2005). It is also impossible to exclude that chronic stress by means 
of p38/stress-activated protein kinase and endoplasmic reticulum stress promotes 
formation in an organism of dormant tumor cells based for many years and decades, 
refracted to the chemotherapy, participating in cancer metastasis formation and relapse 
(Ranganathan et al., 2006). 
It is necessary to say that at animals high efficiency of treatment of a cancer is observed 
which unfortunately is not present at the person and results in vivo cannot be extrapolated 
on the person (Knight et al., 2006). Distinctions are hidden in absence at animals of the 
second signal system (mentality as a whole) which is the imperceptible factor interfering 
with an effective cancer treatment. 
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2.3 Stressful brain and cancer 
Brain – the key body providing adaptive/disadaptive reactions of an organism on stress 
through involving vegetative, endocrine, immune mechanisms (McEwen, 2007). On the 
background of CPS, infringements HPA axis activity and glucocorticoids influences 
structural remodeling dendrite neurons of hippocampus, amygdala, prefrontal cortex occurs 
(Conrad, 2006), actually the atrophy of neurons in limbic structures of the brain responsible 
for processes of adaptation is observed, regulation of vegetative functions, generation of 
emotions and motivations, the organization of complete forms of behavior, etc (Morgan et 
al., 2005). It is worth noticing that reduction of cerebra metabolism in limbic structures of the 
brain in patients with various malignant tumors is observed (Tashiro et al., 1999). It is 
possible to assume that difficult to diagnose (subclinical) infringements of functions of 
limbic systems are formed in cancer patients before detection of new malignant growths on 
a background of CPS cumulative influence. 
Besides, affective disorders (helplessness, depression) which are characteristic of cancer 
patients, are accompanied by dissociated changes in four major brain systems: (1) an 
unbalanced prefrontal-cingulate cortical system, (2) a dissociated HPA axis, (3) a dissociated 
septal-hippocampal system, and (4) a hypoactive brain reward system, as exemplified by a 
hypermetabolic habenula-interpeduncular nucleus pathway and a hypometabolic ventral 
segmental area-striatum pathway (Shumake & Gonzalez-Lima, 2003). Thus, behind a facade 
of serious somatic (neuroendocrine, immune) and psycho-emotional (anxiety, depression) 
disorders at cancer patients infringements of integrative functions of brain systems are 
presumably hidden which can be defined as brain disintegration syndrome (BDS). BDS is 
characterized by infringement of functions of suprasegmentar vegetative structures, 
descending tonic influences on sympathetic-adrenal and pituitary-adrenic devices that is 
shown by decomposition of activity of physiological systems at all levels of an organism. 
Cancer is not only the pathology of genes it is the unique result of cumulative CPS influence 
with cumulative carcinogenic effect of catecholamines and glucocorticoids (Desaive & 
Ronson, 2008), serious infringement of antineoplastic activity of immune system and tissue 
morphofunctional homeostasis, actually, this is illness of a whole organism. However, the 
huge potential of brain is capable to supervise and modulate the processes connected with 
genesis and progression of a cancer (Mravec et al., 2008). 
2.4 Mental depression and cancer 
CPS is closely connected with formation of affective disorders, in particular due to changes 
in expression of a gene 5-HTTLPR responsible for transport of serotonin (Jacobs et al., 2006), 
therefore anxiety and depressive disorders often go together and are characteristic of cancer 
patients (Miller & Massie, 2006). Mental depression, serotonin system and proinflammatory 
cytokines are connected in uniform pathophysiological links participating in carcinogenic 
mechanisms (Cavanagh & Mathias 2008). For a long time there has been consent among a 
significant number of scientists and clinical physicians on depression as etiological factor in 
development of cancer (McGee et al., 1994). Comorbid depressive and/or anxiety disorders 
aggravate development of any chronic disease (Roy-Byrne et al., 2008), influence extremely 
negatively on immune basis of some infectious, autoimmune, cardiovascular diseases and 
malignant tumors (Spiegel & Giese-Davis, 2003; Irwin & Miller, 2007). 
Depression promotes progress of cancer and is a signal of a short life of oncopatients 
however the fact of fatal association ‘‘depression-cancer” is practically ignored in strategy of 
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preventive prophylaxis and treatment of a cancer (Lloyd-Williams et al., 2009). Adverse 
growth forecasts in cardiovascular diseases rate, malignant tumors and depression in the 
world should be paid attention to. By 2020 depression becomes the second leading reason of 
disease in the world after ischemic heart disease (Lopez & Murray, 1998). It is possible that 
depression is pathogenetically connected with development of the specified diseases and 
under certain conditions can act as the starting factor for psychogenic carcinogenesis. 
2.5 Population data 
Data of many population researches allow to see an opportunity of a psychogenic induction 
of malignant tumors. For example, depression and hopelessness can play the important role 
in etiology of breast cancer (BC) (Montazeri et al., 2004; Zhao et al., 2002). The people gone 
through massive stress or daily stress raise BC risk in 3.7 times (Kruk et al., 2004). 
Phenomena of a racial discrimination essentially raise BC rate among black women in the 
USA (Taylor et al., 2007). Population research of 10808 women who have gone through 
divorce or loss of a close person has shown sharp increase in risk of BC disease (Lillberg et 
al., 2003). In one of provinces of Poland the high level of malignant neoplasms has been 
connected with psychological stress on a background of social and economic 
transformations in 80 and 90th years of the last century (Tukiendorf, 2005). Death in war of 
6284 sons led to increase at parents’ disease of malignant tumors of lymphatic and 
hematopoietic systems, melanoma and if the cancer had been diagnosed before loss the risk 
of death has considerably increased (Levav et al., 2000). 
Population research in Italy has shown that occurrence in children tumors of the central 
nervous system and Hodgkin’s lymphoma has been essentially connected with the 
subsequent development in their mothers’ cancer of the respiratory tract and among 
mothers of leukemic children cancers of the lymphohematopoietic system and BC were 
observed (Zuccolo et al., 2007). It has been collected a lot of similar data, however 
mechanisms of interrelations ‘‘mind-cancer” remain unclear. 
2.6 Children psychogenic carcinogenesis 
Greene and Miller informed about possible links of psychoemotional stress with 
development of cancer in children 50 years ago in their work (Greene & Miller, 1958), later 
researchers also paid attention to these links (Jacobs & Charles, 1980). Extremely negative 
influence of prenatal psychological stress and depression on mother–child symbiosis has 
been established up to an arrest of development of fetus and poor birth outcomes (Newport 
et al., 2002; Coussons-Read et al., 2006). Death of one parent during pregnancy is connected 
with high risk of development in the born children four tumor types: childhood acute 
lymphoblastic leukemia, Hodgkin’s disease, embryonic carcinoma of the testis, and 
appendiceal carcinoid tumors (Bermejo et al., 2007). Family psychological stress is associated 
with infringement of children immune system functioning and increase in frequency of their 
disease (Wyman et al., 2007). 
There is an impression that the fetus, neonatus and child even are more sensitive to CPS 
damaging influence in a continuum mother–child and parent–child than adults because of 
full dependence from mother/parent and absence of antistressful strategy of reaction to real 
or alleged dangers. It creates real conditions for a psychogenic induction of tumorogenesis 
in a developing children’s organism. 
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2.7 Cancer in psychotic patients 
The investigation of malignant tumors prevalence in psychotic illness has shown conflicting 
results, however, many authors have found the low level of morbidity and mortality from 
cancer in psychotic patients, except the patients with paranoid schizophrenia and manic-
depressive psychosis in the period of depression, whose cancer rates are dramatically 
increased. For example, cancer patients with breast cancer increased morbidity 9,5 times 
(Damjanovic, A. et al. 2006). These patients are constantly in a state of emotional stress 
thinking about the ways to protect themselves from their persecutors, or loss of feeling of 
pleasure and meaning in life. 
2.8 Spontaneous regression of cancer 
The phenomenon of spontaneous regression of cancer is known for hundreds years and was 
observed in virtually all types of a cancer, but its mechanism remains unclear, confusing and 
controversial. Spontaneous regression of cancer is complete or partial, temporary or 
constant disappearance of all or some parameters of the diagnosed malignant disease in 
absence of medical treatment or treatment without sufficient explanation of regress. The 
various mechanisms of this were suggested: from infection and fever as the causes to the 
role of prayers. However, none of the proposed mechanisms independently alone explains 
the phenomenon of spontaneous regression of cancer. Moreover some researchers report 
about the changes in emotional state immediately before spontaneous regress of malignant 
tumors (Schilder et al., 2004). 
2.9 Schema of psychogenic carcinogenesis 
The basic parts of psychogenic carcinogenesis are presented in Figure 1. The schema allows 
to see participation of a hidden psychogenic component (a) in the development of known  
 
 
Fig. 1. Schema of psychogenic carcinogenesis. 
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key mechanisms of carcinogenesis (b) and formation of the cancer disease closing a vicious 
circle of carcinogenesis (c). Thus, chronic stressful dysfunction of the basic brain systems 
leads to descending tonic influences on pituitary-adrenal and sympathetic-adrenal systems, 
developing of ischemic, metabolic processes and activation of oxidative-nitrosative stress 
(reactive oxygen and nitrogen spices – endogenic carcinogens). Stress damage of the nuclear 
genetic apparatus of cells and oppression of supervising functions of the immune system, 
leading to emergence and growth of a malignant tumor. The formation of the cancer disease 
and inexhaustible emotional stress associated within as a personal reaction to a disease, 
close a vicious circle of carcinogenesis.  
However, the main trigger factor of psychogenic carcinogenesis in a presented scheme 
remained completely undiscovered is a chronic debilitating psycho-emotional stress. How is 
this state formed, what does it mean for a man and what are its consequences? It is impossible 
to form holistic view about psychogenic cancer carcinogenesis without understanding the 
essence of the psychogenic factor. It is impossible to develop a pathogenetic approach in order 
to prevent, treat and rehabilitate the patients with psychogenic cancer. The answers to these 
and other important issues related to the functioning of a person during his life have been 
received in the concept of the dominant purpose of life. 
3. Unity of mind and body: A new system view on health and human diseases 
(concept of life purpose dominant) 
Problems of links between mind and body, ideal and material always attracted attention of 
the scientists and philosophers and within the framework of medicine there has always been 
a clear understanding of necessity in holistic perception of the patients however actually 
approach to the patients appears to be determinative. Unobviousness of influence of mind 
on a body and lack of a system view on psychosomatic links continuity have made modern 
practical medicine somatically focused. It is focused both in diagnostics of diseases and in 
their treatment and preventive maintenance. The scientific search is also mainly focused on 
study of somatic parameters of organism without the account of mind influences on them. 
The appearance of new research technology still carries scientists even more in depths of 
organism. The huge piles of fragmented facts are taken on a surface which are difficult to 
give the system analysis to. At the same time the huge amount of scientific data is kept 
showing extensive damaging influences of chronic psycho-emotional stress (CPS) on 
organism of animals in experiment and on human being in daily life (Ostrander et al., 2006; 
Gidron et al., 2006; Simon et al., 2006; McEwen, 2007; Spinelli, 2009). It is possible to state 
that CPS is an important an etiological and pathogenic factor in development of many 
somatic diseases including “diseases of civilization”: atherosclerosis, cardiovascular disease 
(Knox, 2001; Dimsdale, 2008; Nemeroff, 2008; Shpagina et al., 2008; Roy-Byrne et al., 2008) 
and cancer (Adamekova et al., 2003; Reiche et al., 2005; Mravec et al., 2008). About that has 
been stated earlier in a hypothesis of psychogenic carcinogenesis. Psychogenic factor has 
always been and still remains essential component which mainly defines occurrence, 
development and outcome of human being diseases however in view of its idealness and 
unobviousness it is latent behind a facade of a clinical disease picture and as a rule is left 
untouched by pathogenic treatment. In connection with above stated there is one large, 
difficult and, at first sight, unsolved question: “How to see mind, biological, personal and 
social aspects of a healthy human and a patient in dynamic unity instead of considering 
only separate pathological process?” 
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3.1 The concept 
The answer to this raised question would allow bringing in the proved and purposeful 
corrective amendments to scientific researches, diagnostic, medical and preventive 
measures in work with the patients. We offer the concept of life purpose dominant (LPD) 
which opens a system view on health of a human and process of any serious chronic disease 
formation with participation of mind and shows a possibility to control this pathological 
condition. On a basis of the offered by us LPD's concept lays inter-subject doctrine of a 
dominant as universal, biological principle of work of the nervous centers and vital 
functions of all living systems, general law of the intercentral relations in living organism 
(Ukhtomsky, 1927, 1966). The doctrine of a dominant was created by the academician А.А. 
Ukhtomsky (1884-1942) who is the largest thinker and ingenious scientist of the XXth 
century. However his doctrine has not received a due estimation and recognition neither 
during life of the author nor after his death. His scientific school existed simultaneously and 
in parallel with a school of the Nobel winner academician I.P. Pavlov that was recognized 
by the Soviet power as “sole correct scientific idea”, therefore discovery of the ingenious 
scientist remained unnoticed for a long time. For the sake of justice it is necessary to tell that 
the basic rules of the doctrine of a dominant and a term “dominant” used in the works of 
scientists which have created a lot of the well-known theories: theory of human being 
motivation (Maslow, 1943), theory of installation (Uznadze, 1997), psychological theory of 
activity (Leont'ev, 1978), theory of movement behavior (Bernstein, 1967), theory of dynamic 
localization of mental functions (Luria, 1970), theory of the functional system (Anokhin, 
1970), search activity concept (Rotenberg, 2009) and even a lot in Pavlov's doctrine of 
conditioned reflex appear to be component of the doctrine of a dominant. Really, 
uncountable set of reflexes in complete sense would blow up organism in the first instant of 
the existence if submission to their principle of a dominant when all reflexes work under the 
slogan “everybody for one, one for everybody”. By the way, the formation of each 
conditional reflex under influence of conditional irritant is nothing else as the process of a 
dominant formation which preservation directly depends on supporting influences of 
conditional irritant. 
3.2 Briefly about the doctrine of a dominant of the academician A.A. Ukhtomsky 
Dominant, according to А.А. Ukhtomsky, it not any one topographic certain center of 
excitation in the central nervous system. It is certain constellation of the nervous centers with 
increased excitability in various departments of a brain and spinal marrow, in vegetative 
nervous system as well as it is a temporary association of the nervous centers for the solution 
of the certain task (Ukhtomsky, 1966). Spiral marrow and brain stem, conditional reflexes, 
processes of association, integrated images are equally subordinate to a principle of work of 
dominant reflexes of a spinal marrow where the environment as well as high nervous activity 
is perceived. The dominant is characterized with the following four features: 1) high 
excitability, 2) stability of the excitation, 3) ability to sum (accumulate) coming excitations and 
also 4) inertia (the dominant “insists on itself”). The condition of a dominant is not super 
excitation which would by all means be finished by braking and more or less long persistence 
of excitation “in one place and connected braking in the other”. The dominant is capable to 
pull external irritants together that are not related to it, and do not prevent its development 
but strengthen it. The dominant represents prevailing need, motivation, and aim and is the 
powerful activator of activity. However, any dominant is always temporary and stops in the 
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following cases: complete spontaneous end of dominant condition (for example, any of the 
biological acts), complete termination of reinforcement by adequate irritant and suppression 
by a more powerful competing dominant. It is necessary to pay special attention that at 
incomplete cancellation of adequate irritant, the dominant amplifies, aspires to keep itself. We 
shall return to this situation while considering treatment of human diseases. 
А.А. Ukhtomsky paid special attention to cortical dominant – dominants of the high order 
which are the latent factors of psychological activity. All vital functions of a human being are 
dominant in their sense; they consist of a set of uncountable functional conditions of organism 
consistently changing each other – current dominants. However, there is the main dominant of 
a human to which all current dominants (more precisely subdominants) are subordinated, 
which holds in its power a whole field of spiritual life, defines “spiritual anatomy” and a 
vector of human existence. We dared to name it the life purpose dominant (LPD). 
3.3 Life purpose dominant in a human 
LPD is a non-material construction with material expression, which is formed in mental sphere 
and is shown by the maximal integration of mental and somatic processes, subordination of 
the current subdominants of a human being, maximal sanogenetic and adaptive possibilities of 
organism that allows him to resist to constant pressure of the environmental factors 
successfully. LPD is formed extremely under influence of a complex of verbal and not verbal 
suggestive irritants (processes of education and training, skills development, models of other 
people behavior etc.) which defines the life purpose that a human being aspires to achieve. A 
vivid example of an exclusive role suggestive irritants play in formation of life aims and 
personality is the well known phenomenon of Homo ferus (“Mowgli Syndrome”) (Yousef, 
2008) when children who have been brought up by animals completely acquire all behavior 
stereotypes of animals. In view of suggestive basis of LPD, life purpose and its loss can not be 
clearly realized by a human. For achievement of long-term, instead of momentary goal whole 
organism appears in subordination to its main conductor – LPD. LPD provides coordination of 
asynchronous work of organs and systems, mental and somatic processes, defines a vector of 
apparent chaos of numerous reflexes of organism, current subdominants (biological, mental, 
social etc.) and trajectory of everyday behavior of a human being. The LPD has certain 
similarity to work of ants carrying construction material in an anthill when the vectors of 
movement of separate ants are multidirectional and even opposite, but the resulting vector of 
their movement allows moving construction material in an anthill (Perelman, 2008). LPD 
defines not only functional condition of the central nervous system, high nervous activity and 
vector of behavior of a human being, it defines a functional condition of a whole organism at 
all its levels – from subcellular up to organismic. Let us notice, that at the adult human LPD 
has the most various contents but in a fetus, neonatus and a child LPD is shown by aspiration 
to safety. However, in process of development of a personality which represents a set of 
already holding suggestions, LPD is filled with other suggestive by the contents, that stability 
of LPD depends on. 
3.4 Interrelations between a life purpose dominant and current subdominants of a 
human 
LPD has supporting influences from numerous current subdominants, which do not have 
any direct attitude to it at all. However, there are basic subdominants among numerous LPD 
subdominants – “subdominants of health”, its reinforcement and strengthening, which are 
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actively created only by human being despite of constant action of external irritants 
(unfavorable environmental factors), competing subdominants, menacing formation and 
capable to occupy a place of LPD or even to destroy it. For example, a scientist is 
overcoming inconceivable number of obstacles in search of the truth or an actor is constantly 
aspiring to improve himself to be in demand, to feel love of the spectators and to receive the 
worthy fee. If these people terminate to create basic subdominants, their dominants of life 
purpose by all means will disappear that threatens with heavy mental and somatic 
consequences, we shall speak below about. Restriction of possibilities to create supporting 
basic subdominants is observed among refugees, disabled, prisoners and other people who 
lost life prospect. At the same time use of the minimal possibilities to reinforce LPD allows a 
human to keep his/her health even in conditions of massive chronic psycho emotional 
stress. For example, during the Second World war, some war prisoners in concentration 
camps died quickly and others planned their lives after concentration camps, they washed, 
had a shave, cared for others every day and being in inhuman conditions of existence they 
did not even catch colds at all (Rotenberg & Arshavsky, 1984). There is a great variety of 
examples of huge LPD force in a world history, in daily life and in clinical practice. 
We have to mention numerous situations connected with achievement of life purpose, the 
termination of basic subdominants formation and natural LPD loss. A good example is the 
people with the most favorable financial, economic and social status who have achieved the 
life purpose and any possible well-being but imperceptibly appeared in “without 
dominant” condition – condition of chronic psycho-emotional stress with the subsequent 
development of heavy diseases. 
3.5 Life purpose dominant at an animal 
Proceeding from universality of the doctrine about a dominant for all living systems LPD 
should exist at an animal too. We consider that unlike a human being, LPD at an animal is 
biologically predetermined, formed in the central nervous system, constant at any age and is 
the dominant of safety – filled with aspiration to safety. Unlike human being, the animal 
practically is unable to show own activity in creation of strengthening basic LPD's 
subdominants. At wild animals the strengthening LPD occurs by a natural image under 
action of short-term subdominants – functional condition of an organism arising as a result 
of reactions on acute stressful irritants. At domestication and training of an animal human 
being becomes main irritant in formation of a unique basic subdominant strengthening an 
animal dominant of safety. This understanding is important, as it allows in experimental 
models on animals to simulate loss of LPD, similar to loss of LPD at a human. 
3.6 Role of suggestions in occurrence and loss of a human’s life purpose dominant 
From above stated there is a clear exclusive role of suggestions in life of a human, as LPD and 
personality are a product of systematic suggestive influences. From all variety of irritants 
influencing a human being during his life suggestive influence are capable to destroy LPD 
directly and to become a leading though invisible pathogenic part in development of many 
diseases. In contrast to animal at which the acute stress always strengthens LPD, at a human 
everything depends on various results of intrapsychic processing of suggestive information of 
acute stress. For example, if the threat to life of an animal is finished with flight and LPD 
reinforcement, the threat to life of a human can both support LPD and be finished with its loss 
and development of disease, for example, post traumatic stress disorder. Besides, suggestive 
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influence can in some minutes deprive a human being of life purpose and result in his death 
how an academician V.М. Bekhterev informed in the work describing experiment on a 
criminal sentenced to a death penalty (Bekhterev, 1998). 
3.7 Diseases as dominant conditions 
Any disease of a human being contains all features of a dominant therefore it can be 
considered as pathological dominant condition which is formed under influence of 
somatogenic and/or psychogenic irritants – etiological factors. The dominant dies away and 
disappears according to the doctrine of dominant after termination of adequate irritant. 
However, human diseases as pathological dominant condition do not disappear at complete 
termination of etiological irritants, but become chronic, as are supported by others already 
pathogenic irritants. In this connection, chronic diseases, as pathological dominant condition, 
have the supporting influences on the part of numerous current subdominants. Please note 
that there are pathological basic subdominants among them – “subdominants of disease” 
which are formed under influence of hetero- and autosuggestive irritants. Actually, they are 
pathological reflexes, for example, bronchial asthma attack, spasm of colon, arrhythmia attack 
or more complex cascade of reflex disorders at a relapse of a multiple sclerosis or cancer 
generated in a result of psycho-emotional shocks. These basic pathological subdominants 
(pathological reflexes) become a basis psychogenic component of chronic diseases. 
3.8 Psychogenic component of disease as the basic part of pathogenesis 
Psychogenic component of disease is an indispensable reaction of the person to disease with 
a complex of emotional, intellectual and volitional disorders connected to comprehension, 
experience and attitude of the patient to the condition and also with vegetative component 
which naturally interweaves with a structure of clinical displays of disease that gives it 
qualitatively new features. We consider that namely psychogenic component in human 
being defines development and outcome of human diseases as its basic pathogenic role 
consists of a distortion or blocking of sanogenesis mechanisms. There are no human diseases 
without psychogenic component and this is the cardinal difference of human diseases from 
diseases of animals. It is possible to state that the body does not suffer at influence of the 
unfavorable environmental factors but the mind is always injured, i.e. psychogenic factor 
can not be etiological but it is becomes pathogenic. Psychogenic component cannot be 
missed, deliberately ignored and waved away from it. On the contrary, it is necessary to see 
psychogenic component of disease to reveal pathological basic subdominants, i.e. to 
understand and control it to use successfully during treatment of the patients. 
Thus utter elimination of pathological dominant condition, i.e. the patient’s recovery, 
assumes elimination of not only a set of known etiological and pathogenic irritants 
supporting a pathological dominant but also requires indispensable elimination of a 
psychogenic component of disease. Otherwise, the incomplete elimination of irritants will 
indeed strengthen a pathological dominant of disease, which becomes more active, 
progressing and/or resistant therapy. Unfortunately, this phenomenon is quite often 
observed in clinical practice. 
3.9 The characteristic of basic integrated human functional conditions 
The basic integrated functional conditions of a human organism are defined by the contents 
of his main dominant that allows marking out 5 integrated functional conditions which 
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replace each other during a whole life of a human in direct and opposite directions as a 
result of constant pressure of the various factors (irritants) of an environment: 
i. “Ideal health dominant” is a functional organism condition which is characterized by 
LPD presence with its basic subdominants, maximum integration of psychosomatic 
processes, maximum and adaptive organism possibilities and lack of any chronic 
diseases. 
ii. “Relative health dominant” is a functional condition of organism which is characterized 
by LPD presence with basic subdominants, sufficient integration of psychosomatic 
processes, sufficient sanogenetic and adaptive organism resources, allowing 
compensating any available chronic diseases. 
iii. “Without dominant condition” is a transitive functional condition of organism deprived 
of basic subdominants and LPD which is characterized by disintegration of brain 
systems, psychosomatic processes, progressing reduction of sanogenetic and adaptive 
organism resources, formation of any psychosomatic pathology or decompensation of 
already available chronic diseases. 
iv. “Disease dominant” is a pathological functional condition of organism which is 
characterized with occurrence of a dominant of any psychosomatic or soma psychic 
disease instead of LPD with formation of pathological basic subdominants supporting 
disease. 
v. “Self-destruction dominant” is a pathological functional condition of organism which is 
characterized by occurrence of a dominant condition instead of LPD described by 
aspiration to death – a dominant of death with numerous pathological basic 
subdominants, maximal disintegration of brain systems and psychosomatic processes, 
failure of sanogenetic and adaptive of processes conducting to organism destruction. 
3.10 Dynamics of the integrated human functional conditions within a life span 
The dynamic links and change of the basic integrated functional condition of a human 
organism on a background of constant pressure of the environmental factors (irritants) are 
presented in figure 2. To visualize the dynamic presentation of complex psychosomatic 
processes each integrated condition of a human being is shown as “iceberg of 
psychosomatics” where the surface part – soma, underwater part – mind (psychogenic 
component) and central place in each condition is occupied with predominant dominant 
subordinating numerous current subdominants. All subdominants are formed in the 
central nervous system, in mental sphere, but have obligatory manifestations in soma and 
the speed of these manifestations depends on lag effect of somatic processes (nervous 
reactions, vascular reaction, hormone reaction, exchange processes in bones etc.). In figure 
1: the small black circles are various current subdominants (meals, dream, walking etc.), 
black triangles – basic LPD subdominants, black squares – pathological basic 
subdominants of disease. 
“Ideal health dominant” (see Figure 2, I) which is met in a smaller part of the population 
and more often among young people, turns into “relative health dominant” condition (see 
Figure 2, II) under influence of the unfavorable (pathogenic) factors of an environment 
(trauma, infections, stresses etc.). Thus pathogenic factors (irritants) do not destroy 
predominant dominant – LPD but result in occurrence of some chronic diseases (rather 
serious ones) which appear to be compensated because they become the current 
subdominants subordinate to LPD, and psychogenic component of these diseases carries out 
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not pathogenic and sanogenic role. The people with disabilities participating in Paralympic 
Games or keen people living with HIV/AIDS, elderly people conducting an active lifestyle, 
i.e. actively creating and supporting basic “subdominants of health” can serve as an 
example. The reverse transition from condition II in a condition I seem to be difficult. In case 
of LPD (sense, life purpose) loss under pressure of the environmental factors, a human 
being appears in transitive “without dominant condition”, in power of daily subdominants 
(see Figure 2, III) that is characterized by a condition of chronic consumptive psycho-
emotional stress with its mental and somatic manifestations. For example, loss of the close 
person with whom the plans for the future are connected or loss of any life prospects as a 
result of social shocks (war, terrorism, financial and economic crisis, acts of nature etc.) and 
also others psycho-traumatic situations. A person can stay in a condition “without 
dominant” from several minutes up to several years. Under favorable conditions (the life 
purpose appearance) a person comes back in a condition of “relative health dominant” (see 
Figure 2, II) otherwise he/she stays in power of “disease dominant” (see Figure 2, IV) or 
“self-destruction dominant” (see Figure 2, V). 
“Dominant of serious chronic disease” is represented in some serious chronic disease which 
has arisen in the period of “without dominant condition” (chronic psycho-emotional stress), 
with formation of pathological basic subdominants which make a basis psychogenic 
component of disease. They are manifested both in mental sphere (anxiety, depression, 
phobias etc.), and in somatic sphere (vegetative, neuroendocrinal, neuroimmune disorders, 
etc.) deforming psychosomatic relation and actively participating in pathogenesis of disease. 
There are numerous examples of occurrence of the most various diseases on a CPS 
background including development of malignant tumors (Levav et al., 2000) or multiple 
sclerosis (Li et al., 2004) after loss of the close person. 
“Self-destruction dominant” (see Figure 2, V) always occurs from “without dominant 
condition” (see Figure 2, III) which in turn can arise from “disease dominant” (see Figure 2, 
transition IV in III). Psychogenic component “self-destruction dominant” contains a 
significant number of pathological basic subdominants that makes “self-destruction 
dominant” very strong and complicates reverse transition in “without dominant condition”. 
Psychogenic component of “self-destruction dominant” is always brightly painted and 
clinically is shown through depressive symptomatology, phenomena of feebleness, 
hopelessness, down to catatonoid state with complete refusal of a human of the further life 
prospects and from the life itself, it is psychological capitulation (phenomenon “given-
up/giving-up”) under pressure of the environmental factors with active or passive 
aspiration to death. Somatogenic component “self-destruction dominant” is frequently 
shown through expressed somatic by disorders connected mainly to heavy frustration 
intimate – of vascular system (cardiac arrhythmias, weakness of cardiac activity etc.). A 
vivid example of “self-destruction dominant” is a known phenomenon “voodoo death” or 
psychogenic death (Lester, 2009) which was studied by us in oncological practice 
(Bukhtoyarov & Arkhangelsky, 2006). Psychological capitulation on a background of 
depression results in suicides precedes and accelerates approach of death of the patients 
with diseases of heart (Surtees et al., 2008; Seymour & Benning, 2009), cancer patients 
(Lloyd-Williams et al., 2009; Rodin et al., 2009) and patients with other diseases (Grossardt 
et al., 2009). By the way, self-liquidating behavior of some fans, sectarians or suicide attacker 
also is caused by “self-destruction dominant” arisen under influence of the external 
unfavorable mainly suggestive factors. 
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Fig. 2. “Iceberg psychosomatics”: dynamics of the basic integrated functional conditions of 
the human organism within the life span under constant pressure of the environmental 
factors.  - life purpose dominant (LPD); - current subdominants; ▲- basic subdominants 
LPD; ■ - pathological basic subdominants of illness;  - dominant of serious chronic 
disease;  - self-destruction dominant. (I) Condition “ideal health dominant”: LPD 
presence and its basic subdominants, orderliness of psychosomatic processes, absence of 
illnesses; (II) Condition “relative health dominant”: LPD presence and its basic 
subdominants, equilibrium of psychosomatic processes ensuring remission of any chronic 
diseases; (III) “without dominant condition”: LPD absence, disorder of subdominants, 
disintegration of psychosomatic processes, chronic psycho-emotional stress, possibility of 
transition into condition II; (IV) Condition “disease dominant”: Occurrence instead of LPD 
dominant of serious chronic disease supported by pathological basic subdominants, deep 
disintegration of psychosomatic processes, opportunity of return into condition III. (V) 
Condition “self-destruction dominant”: occurrence of death dominant instead of LPD with 
numerous pathological basic subdominants, practically irreversible disintegration of 
psychosomatic of processes, failure of sanogenesis mechanisms leading to death. 
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3.11 View of an animal from positions of a life purpose dominant concept 
The main differences between a human and an animal are the second signal system (speech) 
and ability to abstract thinking, which defines existence of psychogenic component at a 
human only. The set of integrated functional condition of animal's organism within a life 








Fig. 3. Dynamics of the basic integrated functional conditions of an animal organism within 
a life span on a background of constant pressure of the environmental factors.  - “safety 
dominant” (SD),  - current subdominants (CD). (a) Condition “dominant of life”: presence 
SD, supported CD, integration nervous-somatic processes; (b) Condition “chronic stress 
dominant”: presence of SD but CD mismatch, increasing but convertible disintegration of 
nervous-somatic processes; (c) Disappearance of SD on a background of irreversible 
disintegration nervous-somatic processes conducting to inevitable animal destruction. 
A unique (sole) integrated functional condition with the maximum integration of nervous 
and somatic processes, maximum adaptive and sanogenetic resources is the condition when 
an animal LPD (safety dominant) is kept. We named this integrated condition of an animal 
organism “life dominant” where all current subdominants are subordinated to an animal 
LPD (see Figure 3a). For a wild animal the acute stresses and for a pet is a human being are 
the irritants, which strengthen their LPD. In situations of long influence of unfavorable 
irritants (chemical, physical, biological) there is a threat of LPD loss with chaos of the 
current subdominants, increasing disintegration of nervous and somatic processes, 
reduction of adaptive and sanogenic resources of organism. We named this integrated 
condition of an animal organism “chronic stress dominant” (see Figure 3b) that has a certain 
similarity with “without dominant condition” of a human described also by a CPS 
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condition. LPD does not disappear in this condition only at an animal as its disappearance is 
equivalent to death. “Chronic stress dominant” is supported only by external irritants and is 
capable to reverse transition in “a life dominant” only after the termination of exogenous 
influences. Otherwise, there will be irreversible disorders in organism with LPD loss and 
subsequent destruction of an animal (see Figure 2c). 
The stated representations show that the experimental models on animals can not precisely 
correspond to real events in human organism and require very careful preparation of 
experiments. For example, it is incorrect to run experimental approbation of anti-cancer 
drugs on animals that are in an integrated condition of “life dominant” and/or exposed to 
acute stress as organism of such animals has greatest sanogenetic and adaptive resources, 
which can not be basically present at cancer patients. It would be more correct to put 
animals into chronic stress condition on which background to test action of anti-cancer 
drugs. 
3.12 Example of a system view of chronic disease from positions of the concept life 
purpose dominant - Cancer disease 
In the hypothesis of psychogenic carcinogenesis was shown the scheme of formation of 
basic pathogenic parts of carcinogenesis under CPS influence. Thus, term “chronic psycho-
emotional stress” has remained only general concept not reflecting all depth of its origin but 
from positions of the LPD concept CPS genesis with its known damaging influences on 
organism becomes clear. Our long-term researches have shown that up to an actual making 
out a cancer diagnosis, majority of the patients were in a condition of feebleness, 
hopelessness, helplessness despair (frequently not realized by the patients) which 
characterize LPD loss, appeared CPS. Statistic data prove dramatic increase in possibility of 
malignant tumors diseases with age (Jemal et al., 2008). It may be connected with loss of life 
prospects and plans for the future of an elderly person, in fact this is LPD loss with all 
ensuing negative psychosomatic consequences. Making out diagnosis of a cancer is in turn a 
powerful iatrogenic (suggestive) influence closing a vicious circle of carcinogenesis with 
formation of new additional pathological basic subdominants, supporting and 
strengthening the main pathological dominant – cancer dominant, which strongly occupies 
a LPD place. Modern somatic focused therapy of a cancer does not take into account and 
does not pay due influence to psychogenic component of cancer disease which defines 
development and outcome of a cancer in human. Somatic approach to cancer therapy is not 
capable to explain uncontrollability of carcinogenesis. The reasons for uncontrollability of 
cancer process during somatically focused therapy become clear from positions of the LPD 
concept (see Figure 4). 
The modern complex therapy of cancer (surgery, chemotherapy, radiotherapy) results in 
incomplete elimination of irritants supporting cancer dominant and on the whole 
pathologically integrated condition of organism “disease dominant”, i.e. carries out 
correction of its somatic component only (see Figure 4b) that can even strengthen 
manifestations of cancer disease. Besides, maintenance of psychogenic component of cancer 
dominant and “disease dominant” on the whole creates sufficient conditions for complete 
reflex restoration of its somatic component, i.e. occurrence of a recurrent cancer or 
occurrence of cancer of other tissue localizations at repeated reminding influence of 
psychogenic irritants (see Figure 4c) even after many years of the first cancer incident. In this 
connection, in pathogenically proved complex approach to cancer treatment the effective 
influences on psychogenic component of cancer disease should be stipulated. 
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Fig. 4. The “Iceberg psychosomatics”: schema of psychogenic reproduction of a cancer 
disease (cancer relapse).  – cancer dominant (CD), – current subdominants, ■ – 
pathological basic subdominant CD. (a) Influence of standard anticancer treatment on 
somatic component CD and in general “disease dominant”; (b) “Reconstructed soma” with 
previous psychogenic component (c) Complete reflex reproduction of CD and in general 
“disease dominant” (cancer relapse) during repeated reminding chronic psycho-emotional 
stress. 
4. Psychogenic carcinogenesis: possibilities of psychotherapy in the re-
integration of the immune system and increase survival for cancer patients 
The immunopathology disorders are basis of malignant neoplasms and evident dysfunction 
in cellular immunity, control and differentiation cells mechanism abnormalities, 
immunological tolerance and effective immune reaction impossibility to growing tumor 
(Kim et al., 2007; Finn, 2008). A logical using of various methods of immunotherapy in 
modern oncology was a new step in a cancer treatment but was not as effective as was 
expected (Korman et al., 2006; Chouaib et al., 2006). According hypothesis of psychogenic 
carcinogenesis chronic psycho-emotional stress is always accompanied by 
immunosuppression and relates to a high risk of development and progression of malignant 
tumors. In this case an application of pathogenetically substantiated psychotherapeutic 
methods for correction of immunological dysfunctions is quite logical. Basing on our 20 
years old experience of hypnosuggestive psychotherapy (HSP) in stressed and post stressed 
psychic and psychosomatic disorders treatment we have been developing a method of HSP 
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for pathogenic reasonable influences on psychic state as well as on immune system of cancer 
patients. 
A clinical approbation of our pathogenetically substantiated HSP method in complex 
treatment of cancer patients was conducted in the Clinic of Immunopathology of the 
Institute of Clinical Immunology Siberian branch of Russian Academy of Medical Sciences, 
Novosibirsk, Russia in 2002-2005. In some patients with melanoma and kidney cancer after 
HSP a clinical signs of regression biological age was found: visual acuity enhancement, 
increase vitality and motion activity as well as grey hair and body weight reduction without 
connection with cancer cachexia. We have suggested that a mechanism of revealed 
phenomena is based on stem cells (CD34+). Probably under HSP impact these cells start 
actively migrating from bone marrow to peripheral areas and repopulate different tissues. 
Perhaps we will discover that the telomere length in peripheral blood lymphocytes becomes 
longer. To check this hypothesis we planned to measure an amount of stem blood cells 
(CD34+CD38-) and stem cell progenitors of lymphopoiesis (CD34+CD38+) in peripheral 
blood from patients with stomach cancer during HSP. 
We also measured telomere length as a marker of biological age in lymphocytes from 
peripheral blood of patients. We have also assumed that in the case of HSP method 
efficiency will be achieved to improve survival of cancer patients. In this context we studied 
5-year survival rate of melanoma patients who received HSP course. 
4.1 Materials and methods 
In total, 98 patients took part in immunological studies and studies of cancer patients 
survival. In the immunological study involved 56 patients who were 3 groups: two groups 
were composed of patients with biopsy-diagnosed stomach cancer (n=18) and another one 
was composed of healthy donors (n=38). (1) Psychotherapeutic group (n=9) – patients with 
stomach cancer after surgical treatment but without chemo- and radiotherapy: 3 men and 6 
women aged from 51 to 68 years, mean age 57,1±2,16 years, with stage III – 8 patients, stage 
II – 1 patient. (2) Control group (n=9) – patients with stomach cancer before surgical 
treatment and without any types of treatment: 5 men and 4 women aged from 51 to 71 years, 
mean age 62,1±2,52 years, all patients with stage III. (3) Healthy donors (n=38) were from 4 
to 60 years old with mean age 33,2±12,49 years. It should be noted that all the cancer 
patients did not receive any additional treatment during the study period. 
In the study of 5-year survival was attended 42 melanoma patients which constituted 2 
groups. (1) Psychotherapeutic group (n=21): 7 men and 14 women, average age 46,1 ± 1,7 
years, with stage IV – 11 patients , stage III – 6 patients and stage II – 4 patients. Level of 
functional activity (Karnofsky index) was not less than 70% (82,9 ± 2,41%). (2) Control group 
(n=21) consisted of melanoma patients which was not carried out HSP: 6 men and 15 
women, mean age 46,8±1,9 years, with stage IV – 5 and stage III – 16 patients, Karnofsky 
index 86,2 ± 1,86. Evaluation of survival in melanoma patients with was carried out since the 
beginning of the observation patients. 
4.1.1 CD34+ count, apoptosis and telomere length measurement 
Count of CD34+ cells from patients’ peripheral blood was measured by flow cytometry on 
FACS Calibur (Becton Dickinson, USA) with mouse anti-CD34+ and anti-CD38+ human 
antibody (Becton Dickinson, USA). Apoptosis and telomere length in peripheral 
lymphocytes were measured by Flow-FISH method using Cell QuestPRO. Relative count cells 
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with hypodiploid DNA content (apoptotic cells) were measured by fluorescence of 
intracellular DNA dye 7-AAD on FL3 channel from lymphocyte gate. The measurement of 
the absolute telomere length was made using relative length, by formula y=2041,656 + 
280,987×X (“y” is an absolute length (bp), and “X”- is a relative length in per cents). This 
formula was obtained by converting relative telomere length through absolute length for 5 
donors. The telomere length of 5 donors was measured using Flow-FISH and Southern 
Blotting and then the correlated line was plotted, p=0,0008. 
In the psychotherapeutic group of patients with stomach cancer CD34+ count in peripheral 
blood was measured before and after 4th key session HSP (after 4 weeks) and telomere 
length and apoptosis in peripheral blood lymphocytes was measured before HSP, and after 
3, 5, 7, 9 and 11 weeks after 4th key session of HSP. In control group patients only telomere 
length was measured before surgical treatment. 
4.1.2 Method of hypnossugestive psychotherapy 
The method of HSP is based on strict successive, interconnected, figurative, pathogeneticaly 
substantiated suggestive influences in hypnotic states. This method was described in detail 
previously (Bukhtoyarov & Arkhangelskiy, 2008). This method includes: 1) Establishment of 
hypno-rapport between patient and physician; 2) Hypnotic de-actualization of psycho-
traumatic emotions and experience including a fact of cancer diagnosis; 3) Hypnotic lockout 
of dreams connected with known stress situations which are regularly reproduced in the 
sleep with the corresponding psycho-vegetative reactions. It is needed for the subject’s 
exhaustion of psychogenies and to prevent lingering course. 
4) Hypnotic reproduction of a personal “health standard“ or “health syndrome” – a key 
session of the whole course of HSP. This “syndrome” is based on using widely known 
phenomenon of hypnotic hypermnesia (increased memory under hypnosis) generally used 
for restoration of psychogenic abnormalities of memory. However, it is possible to restore 
memory of heart beat, respiratory rate, glycemic rate, enzyme reaction activity, and 
stereotype of digestive system functions etc. from a specific time in the past (Arkhangelskiy, 
1999). The patient recollects the concrete day (date, month, year) from the past – “model, 
standard” of his health when there was no tumor and he felt well, mentally and physically. 
In a hypnotic state suggestions were conducted using the images that are required to 
retrieve from the memory of cancer patients the ' records” that are well known to the body 
as “health standard”. It should be noted that in this key session HSP hypnotic suggestions 
related to the activation of a great desire, the need for further self-realization in their lives 
were conducted. In fact, these suggestions were aimed at restoring the lost of dominant 
purpose in life. 
5-6) The last two HSP sessions have been focused on patients’ education of self-hypnosis 
under hypnosis. Then patients were given detailed instructions to use autohypnosis for 
prolongation of the medicinal effect, as well as keeping psychic and vital tone of cancer 
patients. 
4.1.3 Statistical analysis 
Statistical calculations were made by methods of descriptive, parametric and non-
parametric statistics (Mann-Whitney U test and Wilcoxon matched pairs test) using 
STATISTICA 6.0 (StatSoft, Inc. USA). An estimate of difference of value was by Student's 
test for depended sample. A significant difference was in p level less 0,05. Cancer patients 
survival was assessed using the Kaplan-Meier method. 
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All patients felt significantly better after HSP in spite of the somatogenic component of the 
disease. Significant clinical changes in health, such as stable elevated mood, appetite, and 
night sleep, as well as increased psychic and locomotor activity and even regression of 
gastric dumping syndrome after gastric surgery were observed within 3-4 weeks after 4th 
session of HSP. 
4.2.1 Stem cells dynamic during hypnosuggestive psychotherapy 
In the same period (3-4 weeks after 4th session of HSP) a stem cell level (CD34+) in 
peripheral blood stomach cancer patients was changed (see Table 1).  
 
Patients Gender Age Stage
Before HSP In a month after HSP 
CD34+38- CD34+38+ ∑CD34+ CD34+38- CD34+38+ ∑CD34+ 
1 (Ani-kin) M 52 III 0,19 0,11 0,30 3,03 0,98 4,02 
2 (Vart-sh) F 57 III 0,18 0,08 0,26 0,42 0,26 0,68 
3 (Bak-ov) M 52 III 0,38 0,28 0,66 0,36 0,17 0,53 
4 (Stya-na) F 51 III 0,30 0,30 0,60 0,84 0,47 1,31 
5 (Mar-ov) M 51 III 0,10 0,16 0,26 1,79 0,47 2,26 
6 (Gur-va) F 68 III 0,07 0,05 0,12 0,56 0,21 0,77 
7 (Gas-ko) F 67 III 0,25 0,11 0,36 0,93 0,11 1,04 
8 (Vag-va) F 56 III 0,11 0,09 0,20 0,82 0,23 1,05 
9 (Mas-va) F 55 II 0,27 0,23 0,50 0,55 0,31 0,86 
Table 1. The level of stem cells in stomach cancer patients after hypnotherapy session, %. 
Stem cell counts of CD34+CD38- were increased from 2 to 17,9 times and CD34+CD38+ 
from 1,3 to 8,9 times. A dynamic of middle values were in the following: CD34+CD38- cell 
counts before HSP was 0,21±0,03 % and in a month after 4th session was 1,03±0,29 % 
(р<0,01); CD34+CD38+ cell counts before HSP was 0,16±0,03 % and in a month 0,36±0,09 % 
(р>0,05). A whole count of CD34+ before HSP was 0,36±0,09 % and after that becomes 
1,39±0,37 % (р<0,01). 
4.2.2 Telomere length in lymphocytes after hypnosuggestive psychotherapy sessions 
In the psychotherapeutic group (average age is 57), before HSP, telomere length in 
peripheral lymphocytes was 5,97kbp but it normally should be 6,23kbp according to 
deduced formula. In the control group without operative treatment an average telomere 
length was 5,7 kbp (average age is 62) but an appropriate normal length should be 6,04 
kbp. This data point in the control group with stomach cancer, without operative 
treatment, has the same telomere length in lymphocytes as another one with operative 
treatment (difference with control is 0,34kbp in both groups). In three weeks after 4th 
session of HSP telomere length became longer (6,42kbp) but without significant difference 
until the fifth week after HSP (p>0,05). But in seven weeks after HSP telomere length 
became significantly longer and had reached 7,06kbp (p<0,05 comparing with value 
before HSP) (see Figure 5).  
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Fig. 5. The telomere length of lymphocytes in stomach cancer patients on the background of 
hypnotherapy. 
4.2.3 Apoptosis level of lymphocytes after HSP sessions 
In seven weeks after the 4th session of HSP we recorded another peak of immunological 
index regarding increased level of apoptotic lymphocytes to 1,7 times (comparing with 






























Fig. 6. The apoptosis level of lymphocytes in stomach cancer patients on the background of 
hypnotherapy. 
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Further dynamics show that nine weeks after HSP telomere length became 6,2kbp, 
remaining there until the end of the study (6,25kbp) and didn’t reach initial level. Telomere 
length in CD4+ and CD8+ lymphocytes population before HSP was shorter of telomere 
length of healthy donors at 0,5kbp (Bukhtoyarov et al., 2008). 
4.2.4 Telomere length depending on age 
We derived a formula of telomere length dependent on age, based on the graphic: Telomere 
length (bp)=8312,18-36,64×Age(year), (p=0,023). As it is shown telomere length has a linear 
distribution with a wide spread of values, so we measured a mean telomere length value 
(see Figure 7). 
 





















p = 0,0234;  y = 8312,18 - 36,64*x
 
Fig. 7. Telomere length in lymphocytes from healthy donors depending on age (n=38). 
4.2.5 Five-years survival rate of melanoma patients treated by hypnotherapy and 
autohypnosis 
Hypnosuggestive psychotherapy course in melanoma patients group started almost 1 year 
(0,91 ± 0,17 years) after the beginning of the observation of patients, and from this point the 
survival curves for cancer patients of psychotherapeutic group went to “lethal crossroads” 
the control group in which a survival rate being significantly lower (p <0,05) within 5 years 
of observation (see Figure 8). 
 
4.3 Discussion 
From the standpoint of hypothesis of psychogenic carcinogenesis and the life purpose 
dominant concept the psychogenic factors are important in the pathogenic occurrence, 
development and recurrence of malignant tumors. It is logical to assume that psychogenic 
factors may act in the opposite direction, blocking the mechanisms of carcinogenesis.  
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Fig. 8. The 5-year survival rate for melanoma patients after hypnotherapy (n=42). 
In order to practice these assumptions, it was necessary to apply this method of 
psychological impact on cancer patients that would provide the most effective influence on 
psychogenic factors of carcinogenesis. From our own clinical experience, this method could 
be hypnotherapy, but with compulsory use of pathogenesis-related therapeutic suggestion. 
The use of hypnotherapy in oncology has a long history (Sacerdote, 1966), however, the 
therapeutic suggestion used for were exclusively symptomatic orientated (Marchioro et al., 
2000; Montgomery et al., 2007; Jacobsen & Jim, 2008; Schnur et al., 2008; Monti et al., 2008). 
We purposefully developed the technique of hypnotherapy with the compulsory use of 
pathogenetically important therapeutic suggestions. 
Thus, hypnosuggestive reproduction of a personal “standart of health” (4th session HSP) 
and the subsequent self-hypnosis sessions suggested that the positive changes in the 
immune system of cancer patients are possible in the case of sustained recovery in memory 
of the functional parameters of the body associated with the personal “standart of health” 
(when there no malignant tumor), positive changes in the immune system of cancer 
patients. A search for cellular-molecular mechanisms of biological age regression symptoms 
has found a hypnosuggestively induced mobilization of hematopoietic stem cells from bone 
marrow (immunofenotype CD34+CD38-) and lymphopoietic stem cells (immunofenotype 
CD34+CD38+) with initial gender-age average rates. Although it is known that in with 
breast cancer patients peripheral blood stem cell rates are 2,5 times lower than in healthy 
people (Rusé-Riol et al., 1984). No scientific publications reported earlier the possibility of 
hypnosuggestive mobilization of CD34+ cells. But there is data about hard mobilization of 
CD34+ in old people and cancer patients, especially with chemotherapy because of the 
inhibitive influence of high serum TGF- concentration (McGuire et al., 2001). This feature 
Start  of hypnotherapy
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excludes a possibility of spontaneous CD34+ mobilization in cancer patients and confirms 
no randomness of CD34+ mobilization in patients with psychotherapy due to HSP. 
Telomere length in lymphocytes from cancer patients in both groups was shorter than in 
lymphocytes from healthy donors of the same age, at the average 0,34kbp (Fig. 7) and 
corresponding to cell age of cancer patients 5 years older. These data indicate an “earlier 
aging” and functional defect of peripheral lymphocytes involved in initiation, regulation 
and efficiency of anti-tumor immunity that confirms a known compromise of the immune 
system in cancer patients. It is well known that a telomerase activity and telomere length in 
T-, B-lymphocytes and NK-cells from healthy donors decrease with aging (Son et al., 2000; 
Ouyang et al., 2007), but after incubation of normal T-cells with cancer cells for 6 hours the 
telomere length in normal T-cells becomes significantly shorter (Montes et al., 2008). There is 
data about a connection between a positive clinical effect of immunotherapy by antigen and 
co-stimulating promotion and increase of telomerase activity in T-lymphocytes. For 
example, melanoma regression by effective immunotherapy is associated with increased 
telomere length to 6,3kbp, whereas without effect telomere length was 4,9kbp (Zhou et al., 
2005). 
The possibility of hypnosuggestive induced increase of telomere length at the average 
1kbp (Fig. 5) and indicating transient decrease in age at the average of 10 years was first 
shown in this study. Perhaps HSP has reached disappearance of immunosuppression 
typical for cancer patients and activation of T cell renewal process. It becomes apparent by 
the increase of stem cells value and telomere length elongation. At the same time 
appearance of a new pool of lymphocytes should accompany the maintenance of a general 
number of lymphocytes. Therefore a mechanism of feed-back regulation for maintenance 
of cell homeostatic balance, such as a physiological death of cells by apoptosis, was 
activated. Actually, in patients with stomach cancer, at seven weeks, telomere length 
elongation in lymphocytes was simultaneous with lymphocyte apoptosis that increased to 
1,7 times and confirmed the renewal process of lymphocytes after HSP. Data thus 
confirms a possibility of immune system reintegration in cancer patients by 
hypnosuggestive psychotherapy. It may happen at the expense of active acceleration of 
complex neuro-immuno-endocrinic regulation mechanisms, determinative stem cell 
mobilization from bone marrow, telomere length elongation, and renewal of circulating 
lymphocytes. The proposed mechanism of updating the immune system of patients with 
the stomach cancer on the background of our proposed method of hypnotherapy is shown 
in Figure 9. It is possible that the increase in the 5-year survival rate for melanoma 
patients has been associated with this mechanism. 
Early in 2008, after the publication of preliminary results of our studies (Bukhtoyarov & 
Arkhangelskiy, 2008), in American colleges led by Elizabeth H. Blackburn, in his study, 
obtained similar results (Ornish et al., 2008). Thus, in 30 patients with biopsy-diagnosed 
low-risk prostate cancer during the course of the three-month comprehensive lifestyle 
changes showed the reduction of psychological distress associated with telomerase 
activity increased 29,84% in peripheral blood mononuclear cells. This confirms the 
existence of the possibility of non-pharmacological effects on the activity of telomerase, 
telomere length and indicates the reproducibility of our results that we received for the 
first time that increases their credibility. The research results show the particular 
importance of pathogenic significance of psychotherapeutic effects in treatment and 
rehabilitation of cancer patients. 
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Fig. 9. The scheme proposed updates of the immune system of cancer patients on the 
background of hypnotherapy. 
5. Psychogenic carcinogenesis: Possibilities of medication psycho-
correction in the management of anti-tumor immunity of cancer patients 
Despite the ancient history antiquity of hypnotherapy, we only consider it as a modern 
scientism method of clinical trials of sick human, cancer patients in particular, that yielded 
some interesting practical results based on our preliminary theoretical research. However, 
the main drawback of hypnotherapy is its complexity and the need for special training, 
which significantly limits its applicability in clinical practice. Thus, taking into account the 
previously obtained practical results of hypnotherapy, we hypothesized that the medication 
correction of psycho-emotional disorders, of cancer patients in combination with advanced 
special psychotherapy conversation will have positive effects on the anti-tumor activity of 
the immune system of cancer patients and provide for the cancer of anti-disease. Similar 
psycho-emotional disorders and the disorders of the same type of anti-tumor immunity 
regardless of the tissue localization of cancer are formed in cancer patients under 
psychogenic carcinogenesis. These assumptions, in combination with unknown prevalence 
of psychogenic carcinogenesis but compulsory psychogenic component of cancer disease in 
any type of human cancer allowed us to carry out psychoimmunology research of cancer 
patients in one group without separating them into separate nosology. 
5.1 Materials and methods 
The study was conducted in 2007-2010 in the Center for Psychoimmunology, Kaliningrad, 
Russia. 90 cancer patients, 78 women and 12 men aged: 30-40 years - 6 (6,7%), 41-50 years – 
27 (30%), 51-60 years – 41 (45,5%), over 61-70 years – 11 (12,2%), 71-80 years – 5 (5,6%) 
patients, were involved in the study (smoking – 17 (18,9%), non-smokers – 73 (81,1%). The 
patients with 17 types of malignant tumors, predominantly, breast cancer – 34 (37,8%), 
ovarian cancer – 10 (11,1%); melanoma – 6 (6,7%), uterine cancer – 6 (6,7%), kidney cancer – 
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6 (6,7%), rectal cancer – 5 (5,6%), colon cancer – 4 (4,4%); other sites – 19 (21%) were involved 
in the study. Cancer stages: I – 15 (16%), II – 33 (35%), III – 26 (29%), IV – 16 (19%). All cancer 
patients randomly assigned after the completion of the standard combined treatment of 
malignant tumors: only surgery – 39 (43,3%), surgery and chemotherapy – 26 (28,9%), 
surgery, chemotherapy and radiotherapy – 14 (15,7%), surgery and radiotherapy – 4 (4,4%), 
only chemotherapy – 4 (4,4%), only chemo- and radiotherapy – 1 (1,1%) patients. No 
treatment was given to 2 (2,2%) of patients. The time after surgery varied from 1 month to 12 
years and among them from 1 month to 1 year – 42 (50,6%), 1-3 years – 25 (30,1%), 3-5 year – 
10 (12%); over 5 years – 6 (7,3%). 
5.1.1 Psychometric testing of the cancer patients 
The diagnosis of psycho-emotional disorders and evaluation of psychocorrection was carried 
out clinically and with psychometrically using the following methods and rates: Hospital 
Anxiety and Depression Scale (HADS) – Anxiety and Depression; State-Trait Anxiety 
Inventory Scale (STAI) – Stait Anxiety and Trait Anxiety; Symptom Checklist 90 (SCL-90) – 
Somatization (SOM), Obsessive-Compulsive (OC), Interpersonal Sensitivity (IS), Depression 
(DEP), Anxiety (ANX), Hostility (HOS), Phobic Anxiety (PHOB), Paranoid Ideation (PAR ), 
Psychoticism (PSY), Global Severity Index (GSI). The quality of life was measured with SF-36 – 
Physical Functioning (PF), Role-Physical Functioning (RP), Bodily Pain (BP), General Health 
(GH), Vitality (VT), Social Functioning (SF), Role-Emotional (RE), Mental Health (MH). 
5.1.2 Evaluation of specific anti-tumor activity of the immune system 
Antitumor activity of the immune system was assessed by skin test of the delayed type 
hypersensitivity (DTH) reaction on the tumor-associated antigens, which were used as a 
lysed human melanoma cell line BRO in the amount of 25 thousand cells in a test. Human 
melanoma cell line BRO obtained at the Institute of Cytology RAS (St. Petersburg, Russia). 
As shown above (Wang, 1997), there are all kinds of tumor-associated antigens characteristic 
of solid tumors on the melanoma cells. The selected dose is not immunogenic, does not 
cause allergic reactions and other side effects and is diagnostic. Score samples (the diameter 
of redness in mm) were carried out in 12 hours (the peak response in most cases) after the 
intradermal administration on the forearm. 
5.1.3 Measurement of plasma cortisol level 
The measurement of plasma cortisol levels before and after medication psycho-correction 
carried out an enzyme-linked immunosorbent assay (ELISA) method for each cancer patient 
at 3.30 p.m.± 30 minutes with using a commercial kits (SteroidIFA-cortisol-01 ALKOR Bio, 
Saint-Petersburg, Russia). The normal range for afternoon blood cortisol levels in an adult 
human are 83 to 359 nmol/L. 
5.1.4 Multiplex cytokine analysis (Human 30-Plex) 
Storage of native plasma samples (at -80ºC) each of cancer patients were obtained before and 
after medication psycho-correction. Multiplex testing service (Human Cytokine Panel 30-
Plex, 96 Assay-Points) based on Luminex xMap-Technology: IL-1ǃ, IL-1RA, IL-2, IL-2R, IL-4, 
IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40⁄p70), IL-13, IL-15, IL-17, TNF-ǂ, IFN-ǂ, IFN-Ǆ, GM-
CSF, MIP-1ǂ, MIP-1ǃ, IP-10, MIG, Eotaxin, RANTES, MCP-1, VEGF, G-CSF, EGF, FGF-basic, 
HGF, carried out in Microbionix GmgH (Franz-Josef-Strauss-Allee, 11, Raum D2.2.46, 93053 
Regensburg, Institute of Medical Microbiology and Hygiene, Germany). 
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5.1.5 Medication psycho-correction of cancer patients 
Mental disorders correction was carried out strictly individually with drug therapy using 
various anxiolytics, antidepressants, and their combinations. The following medications 
were used: afobazol, diazepam (microdoses), fluoxetine, coaxil, ixel, velaxin, paxil, 
valdoxan. The main goal of medication psycho-correction was the complete elimination of 
psycho-emotional disorders in cancer patients. In case of the absence of the clinical effect or 
the occurrence of side effects the drug and treatment scheme were replaced in the case the 
side effects did occur. 45 patients agreed to continue participating in the study after 
knocking mental disorders. 
5.1.6 Statistical analysis 
The statistical data processing was done using STATISTICA 6.0 (StatSoft, Inc. USA). The 
level of statistical significance used a p-value less than 0,05. Correlation analysis (Pearson's 
correlation coefficient) was used to study the relationship between psychometric and 
immunologic parameters, as well as to study the proposed immunomodulatory effect in the 
elimination of psychogenic immunosuppression during medication psycho-correction. In 
this case, the correlation is made between the «Before» (B) medication psycho-correction and 
derived quantity “After : Before” (A/B), reflecting the trends of indicators (Kozhevnikov et 
al., 2004). This method of statistical analysis was used because many parameters have 
changed by amounts exceeding the error of the method and direction of changes in the 
parameters is reversed. 
5.2 Results and discussion 
The anamnesis revealed that 79 cancer patients (87,8%) attributed the emergence of their 
disease with long-term psycho-emotional stress. Various mental disorders predominantly 
anxiety-depression spectrum were identified in 95,6% of cancer patients by clinico-
psychiatric study that differs a great deal from commonly-accepted opinion concerning 
psychopathology at cancer patient (Miovic & Block, 2007). Most cancer patients have mental 
disorders regardless of types of malignant tumors. According to International Classification 
of Diseases (ICD-10) the disorders distribution was as follows: generalized anxiety disorder 
(F41.1) – 31 (36,0%), mixed anxiety and depressive disorder (F41.2) –10 (11,6%), prolonged 
depressive reaction (F43.21) – 10 (11,6%), mixed anxiety and depressive reaction (F43.22) – 
28 (32,6%) and organic anxiety disorder (F06.4) – 7 (8,2)%, which in our opinion it was a 
complication chemotherapy. It is worth mentioning that work with such patients including 
the medication psycho-correction, contains difficulties that were determined by the 
peculiarities of psychical disorders within «chemo brain» phenomenon (Staat & Segatore, 
2005). There were only 4 patients (8,9%) of 45 taking part in psycho-correction who required 
less than one month. 32 patients (71,1%) required 1 to 3 months, while 9 patients (20%) 
required 3 months psycho-correction. The time required for medication psycho-correction 
had no correlation (p>0,05) with disease stage, time after surgery and the severity of mental 
disorders. We came across the bad compliance at some cancer patients after the effective 
removing their psycho-emotional disorders. The patients felt very well and their further 
participation in their rehabilitation program considered useless. The dynamics of the tested 
parameters before and after medication psycho-correction of cancer patients are presented 
in Table 2. 
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Hospital Anxiety and Depression Scale (HADS): 
Anxiety 9,5 (0,44) 4,4 (0,28) 0,0001 
Depression 7,6 (0,46) 3,2 (0,34) 0,0001 
State-Trait Anxiety Inventory Scale (STAI): 
Stait Anxiety 39,1 (1,17) 28,6 (1,28) 0,0001 
Trait Anxiety 40,3 (1,14) 29,9 (1,26) 0,0001 
Symptom Checklist 90 (SCL-90): 
SOM 1,31 (0,07) 0,90 (0,08) 0,0001 
O-C 1,17 (0,07) 0,74 (0,06) 0,0001 
I-S 0,97 (0,11) 0,60 (0,07) 0,025 
DEP 1,38 (0,08) 0,82 (0,07) 0,0001 
ANX 0,92 (0,06) 0,52 (0,11) 0,025 
HOS 0,78 (0,06) 0,52 (0,07) 0,009 
PHOB 0,47 (0,05) 0,26 (0,06) 0,012 
PAR 0,69 (0,06) 0,56 (0,07) >0,05 
PSY 0,76 (0,06) 0,50 (0,06) 0,007 












 PF 69,2 (2,97) 80,0 (2,80) 0,011 
RP 29,4 (5,46) 56,8 (5,86) 0,001 
BP 51,8 (3,50) 71,4 (3,67) 0,0001 









 VT 46,3 (3,11) 66,7 (2,67) 0,0001 
SF 59,3 (4,18) 80,6 (2,78) 0,0001 
RE 34,2 (6,11) 68,6 (6,35) 0,0001 
MH 45,8 (2,96) 68,5 (2,19) 0,0001 
Delayed type hypersensitivity reaction on the tumor-associated antigens: 
DTH reaction, mm 2,68 (0,39) 7,80 (0,96) 0,0001 
Table 2. Dynamics of the tested parameters in cancer patients “Before-After” medication 
psycho-correction. 
As it is shown in the table that the presence of mental disorders in cancer patients before 
medication psycho-correction have been identified clinically and confirmed by 
psychometric parameters. As a result, medication psycho-correction significant 
improvement occurred in almost all psychometric parameters and significantly improved 
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quality of life for all indicators of physical and mental health SF-36 that led to an increase in 
DTH skin reaction on the tumor-associated antigens (p=0,0001), i.e increasing the specific 
antitumor activity of the immune system of cancer patients. The inverse correlations found 
between DTH skin reaction and psychometric parameters: Stait Anxiety (r= -0,34; p= 0,001) 
and Psychoticism (r= -0,21; p= 0,043). However, if the preliminary high indicators of DTH 
skin reaction (up to 15-16 mm) at cancer patients without psycho-emotional disorder (4 
patients) are excluded, the true correlation connections have been discovered with great 
number of parameters of the psychical condition and the standard of living (see Table 3). It 
is possible, that these four cancer patients without psycho-emotional disorders their 
carcinogenesis was non-psychogenic. Thus, we can assume that effective medication 
psycho-correction and improvement of the quality of life of cancer patients can eliminate the 
psychogenic immunosuppressive effects on the immune system and create the conditions 
for controlling of specific anti-tumor immunity of cancer patients irrespective of the cancer 
types. 
The results of Multiplex study (Human Cytokine Panel 30-Plex) during medication psycho-
correction are paramount importance. The concentration of the following 14 cytokines: IL-
1b, IFNǂ, IL-1RA, IL-2, IL-4, IL-5, IL-7, IL-10, IL-13, IL-15, IL-17, G-CSF, GM-CSF, IFN-Ǆ was 
below lower limit of detection and they were excluded from the analysis. The significant 
multidirect changes took places as a result of effective medication psycho-correction among 
the determined concentration of cytokines. The statistically approved differences were not 
discovered (p>0,05) during the comparison of the average concentrations of cytokines.  
 
Parameters 



















Table 3. Correlations between DTH skin reaction and tested parameters before medication 
psycho-correction (n=86). 
Multidirects changes in the cytokine profile reflected the modulating influence of effective 
medication psycho-correction in relation to concrete cytokines participating in the processes 
inflammation, angiogenesis and cellular immunity. The negative coefficients of the 
correlations – rB/(A:B) indicated on the modulating effect of medication psycho-correction 
(when high the cytokine concentrations are reduced, and low concentrations are rising) (see 
Table 4). 
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VEGF 8,38 (0,94) 6,83 (0,80) -0,56 0,005 
FGF-basic 17,6 (4,06) 10,8 (1,19) -0,74 0,034 
IL-12p40/p70 59,1 (3,76) 54,8 (4,19) -0,57 0,0001 
RANTES 1732,5 (133,9) 1872,5 (190,8) -0,53 0,001 
MCP-1 635,6 (31,5) 605,9 (36,8) -0,57 0,0001 
IL-1RA 332,4 (51,3) 234,2 (17,7) -0,72 0,013 
IP-10 49,9 (5,08) 38,1 (3,94) -0,37 0,015 
Table 4. Modulating effects of medication psycho-correction on the plasma cytokine levels 
(Cytokine 30-Plex). 
Where rB/(A:B) – correlation coefficients between the values «before» and the quotient of the 
«after : before». 
In our opinion, multidirect individual changes in cytokines concentration at cancer patient 
reflected the peculiarities of intercellular interaction in the organism of every patient in 
respons to medication psycho-correction. It may be suggested that the discovered changes 
of the cytokine profile had anti-tumor direction at the background improving psycho-
emotional state and increase specific anti-tumor activity of the immune system at cancer 
patients. Thus, for instance increase of cytokines, the concentration connected with the 
angiogenesis at some cancer patients may be connected with microcirculation improvement 
the tissues ischemisation decrease and the increase of their accessibility to the cells of 
immune system at the expense of angiogenesis activation. At the same time, the decrease of 
the initially high concentration of cytokines connected with angiogenesis at other cancer 
patients after medication psycho-correction may reflect the processes of neoangiogenesis 
suppression. 
As another example multidirect changes of cytokines concentration participating in cell 
immunity mechanism can be provided. Thus, the increase of these cytokines concentration 
at a number of cancer patients after psycho-correction can point out at the activation cell 
immunity and anti-tumor immunity as well. At the same time, the decrease of these 
cytokines at some cancer patients after psycho-correction may evidence the cell immunity 
suppression and the activation of tissue reparation processes (fibroses, regeneration) that are 
in reciprocal correlations and accompany inflammation processes. It should be noted in 
particular that the normal reparation process of tissues is accompanied by physiological 
suppression cell-mediated immunity including anti-tumor immunity. An absences of 
suppression the cellular immunity processes slow down and distorted because the cells 
proliferation are eliminated as tumor transformed cells, because on the fact the proliferating 
cells express the differentiation and tumor-associating antigens. The reciprocal correlation of 
cellular immunity and reparation process are described as the balance between T-helper-1 
and T-helper-2 lymphocyte subpopulations with the production the cytokines 
correspondent to them in the scientific literature. Resulting from the data received, we 
suggest that practically unique spectrum of molecular signaling, cytokine profile and genes 
expression at each cancer patients is formed on all stages of appearance and development of 
malignant tumor disease. That implies the lack of perspective in applying linear logic in the 
research of infinite molecular-genetic configuration that may be found at cancer patients. In 
particular, this is connected with the cases of psychogenic carcinogenesis, when pathological 
and sanogenetical processes, taking place on the cellular and molecular-genetic levels are 
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secondary, effectory in the relation to central nervous system and higher nervous activity of 
man. It is obvious, that the linear logic with its attempts of isolated medication only on 
cellular, molecular and genetic levels aimed at governing malignant tumor processes will 
prove to be inappropriate in case of psychogenic carcinogenesis. This suggestion may be 
considered to be true concerning the use of any vaccine, immunomodulators on any other 
anti-cancer drugs because all of them will act in the conditions of suppression and distortion 
of the immune system reactions determined by the psycho-emotional disorders of cancer 
patients. The final result of such medication influence is connected with the danger of cancer 
process strengthening at the expense of even greater activation of distorted immune 
reactions at cancer patients. 
Dwelling on the above presented scheme (see Figure 1), the stress hormones in particular 
cortisol that is the biologically active component of the HPA axis, turn out to be the essential 
phase psychogenic carcinogenesis. The mean values of cortisol plasma levels before and 
after medication psycho-correction of cancer patients had no differences (p> 0,05) and did 
not differ from the normal amounts. However, the initial levels of cortisol had backward 
correlations with the number of psychometric indexes: HADS – Anxiety (r= - 0,26; p= 0,014) 
and 5 parameters of Symptom Checklist 90 – OC (r= - 0,26; p= 0,014); DEP (r= - 0,20; p= 
0,025); ANX (r= - 0,24; p= 0,026); PAR (r= - 0,32; p= 0,003); GSI (r= - 0,26; p= 0,014). 
Moreover, the direct correlation of cortisol and receptor IL-2R (r= 0,24; p= 0,022) that may be 
the indicator of quantity Treg cells suppressing the specific anti-tumor immunity has been 
discovered (Yang & Ansell, 2009; Fort & Narayanan, 2010). These data, to some extent, could 
clarify the mechanism of specific anti-tumor immunity suppression at cancer patients with 
psychogenic carcinogenesis. It would be appropriate first to effectively suppress the psycho-
emotional disorders at cancer patients with psychogenic carcinogenesis that allows to 
remove the psychogenic immunodepressive influence from the central nervous system 
(higher nervous activity) and create the favourable conditions for using various 
immunological drugs, anti-tumor vaccines and other anti-tumor drugs. However, we failed 
to define and understand the cytokine mechanism of activation of specific anti-tumor 
immunity at canser patients after elimination of psycho-emotional disorders. Obviously, it is 
necessary to employ the other research techniques that could allow to find out the 
interconnections and supra-cytokine mechanism of management of anti-tumor immunity at 
cancer patients from the central nervous system. 
6. Conclusion 
It is obvious that the cancer problem become global long ago, the problem that affects the 
countries all over the world and all levels of the society. We have faced the amazing paradox 
– the illness and mortality from cancer are ever increasing with the rapid development of 
science. Which global carcinogenic factor effects the people all over the world in the way 
that simultaneously damages DNA cells and suppresses anti-tumor immunity? We believe 
that it is practically impossible to give the answer to this question taking into account three 
known types of cancerogenesis (chemical, physical, biological). The clinical practice, the 
results of numerous but various scientific research and the life itself pont out at the fourth 
mechanism of the carcinogenesis – psychogenic carcinogenesis. We assume that in case of 
formation of any tumors, psychogenic carcinogenic influences always take place and act 
both independently and in combination with the chemical, physical and biological 
carcinogens, essentially making their tumorogenic effect easier. In case of psychogenic 
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carcinogenesis the cancerogenic factor is the chronic psychoemotional stress, the damaging 
influence of which is well known and can be noticed at all levels of the research of a human 
– from genic level to population one. The definite indicator of the existence of chronic 
psycho-emotional stress at man can be anxiety disorders and affective disorders, especially 
depression (subdepression) that has been considered the global problem of the modern 
society and world medicine (Daly, 2009). It is believed that cancer patients with depression 
have somato-psychic origin and is secondary in relation to somatic pathology. 
However, earlier we obtained the results of multicentre anamnestic research of more than 
1200 cancer patients with 23 types of cancer in which we discovered that about 70% of 
patients had the symptoms of anxious and depressive disorders during 1,5 years before they 
had been diagnosed the cancer disease (Bukhtoyarov & Arkhangelskiy, 2008). These psycho-
emotional disorders occurred as a result of various psycho-traumatic events that led to the 
state of helplessness, hopelessness and formed the vision of impossibility of achieving 
personal aims and self-realization. In fact, these pathological states reflected the loss of 
objective and the meaning of life, that quite often are not realized by man. The analysis of 
the data obtained become the basis that allowed us to create of life purpose dominant 
concept describing the formation of the essential functional states of man during the life. We 
suggested that the cancer disease at some patients is the result of the consequent destruction 
of two essential closely connected with each other and perhaps “ancient” basic 
psychosomatic entities of the human organism purpose the meaning of life (i.e. life purpose 
dominant) and supervisory functions of the immune system. We believe that psychogenic 
carcinogenesis is the particular case of such disorders that is why other psychosomatic 
combinations are possible in case of other chronic diseases. The loss of the purpose and the 
meaning of life accompanied in the cascade of increasing disintegration processes at all 
levels of the organism that manifested the mosaic of the psycho-emotional disorders, 
metabolic and immunological disorders that form the basis of psychogenic carcinogenesis. 
The phenomena of disintegration, dissociation of functions and failure of cellular 
cooperation in cancer, create great difficulties in the scientific search of linear 
interconnections in the carcinogenic processes, in the formation of corrective conclusions 
only on the basis of cellular-molecular-genetic research. It is obvious that the holistic 
approach to the research of cancer problem at man requires to take it psychogenic 
compound in the compulsory account. 
There exists a huge amount of facts in the scientific literature that point out at the close 
connection of positive emotional states (subjective well-being contributes) with the indicator 
of the good physical health: low blood pressure, high versus low density lipoprotein 
cholesterol, longer telomere length, age adjusted, rapid wound healing, renal and hepatic 
reserves and etc., but the conditions for reaching the stuble subjective well-being contributes 
up to now remain unknown (Diener & Chan, 2011). We consider that the main condition of 
subjective well-being contributes is the existence of life purpose dominant in man that 
ensures the maximum integration of psychic, somatic, sanogenetic processes, that creates the 
conditions for preserving good health and longer life expectancy. As far as the hypotheses of 
psychogenic carcinogenesis and life purpose dominant is concerned the direct correlation of 
the cancer desease and human aging to greater extent is explained by decreasing with the 
age the life perspectives, plans for the future and easiness with which the life purpose 
dominant is lost and thus results in chronic exhausting psycho-emotional stress. 
The results of the current research have shown the close interconnection of psychical state 
with somatic processes at cancer patients regardless the type of cancer. At the background 
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of the significant improvement of psychical state and life quality of cancer patients a number 
of previously unknown somatic phenomena has been described. They are as following: 
psychogenically caused stem cells mobilization, psychogenically caused increase of telomere 
length in lymphocytes, psychogenically caused increase of lymphocyte apoptosis, 
psychogenically caused modulation of cytokines in blood native plasma and 
psychogenically caused increase of specific anti-tumor activity of the immune system 
(increase of the delayed type hypersensitivity reaction on the tumor-associated antigens). 
We can assert that mind is the basis of generalization of the cancer process, mind is a 
promoter of cancer. Nevertheless, it is quite obvious that we have only made the first 
modest steps in psychogenic carcinogenesis research and the main difficulties of the 
research are connected with the complexity of the identification of the beginning of cancer 
process and individual “carcinogenic dose” of psycho-emotional stress. The share of 
psychogenic carcinogenesis in the whole structure of carcinogenesis also remains unclear. 
Dwelling on the results of the research, we suggest three clinical criteria of psychogenic 
carcinogenesis and the two of them are sufficient to suggest the existence of psychogenic 
carcinogenesis at a particular cancer patients: the presence of psychogenic anamnesis, 
psycho-emotional disorders and suppression of specific anti-tumor activity of the immune 
system. We strogly believe that the data of the presented research will prove useful both in 
the scientific search and in clinical practice with cancer patients. 
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